Personal and professional use of menopausal hormone therapy among gynecologists: A multinational study (REDLINC VII).

Background: Previously, the REDLINC VI study showed that the main reason for the low use of menopausal hormone therapy (MHT) was its low rate of prescription by doctors.

Objective: To determine the use of MHT and perceived related risks among gynecologists.

Methods: A self-administered and anonymous questionnaire was delivered to certified gynecologists in 11 Latin American countries.